Dr. Michael Parsons, a board-certified neuropsychologist specializing in brain tumors, and Dr. Jörg Dietrich, a neuro-oncologist at Harvard, delve into the complex interplay between cancer therapies and brain health. They unpack how systemic treatments like chemotherapy can lead to cognitive challenges, including the infamous 'chemo brain.' The guest experts also explore the fascinating realm of immunotherapy, its revolutionary effects, and associated cognitive risks. Their insights shed light on the vital role of neuropsychologists in assisting cancer patients navigate these challenges.
